Skip to main content
Top
Gepubliceerd in: Quality of Life Research 3/2020

28-11-2019

Responsiveness and minimal clinically important difference of TNO-AZL Preschool Children Quality of Life in children with cerebral palsy

Auteurs: Chia-ling Chen, I-hsuan Shen, Hsiang-Han Huang, Chung-yao Chen, Yi-ting Hsiao, Ching-yi Wu, Hsieh-Ching Chen

Gepubliceerd in: Quality of Life Research | Uitgave 3/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To examine the responsiveness and minimal clinically important difference (MCID) of the TNO-AZL (Netherlands Organization for Applied Scientific Research Academic Medical Centre) Preschool Children Quality of Life (TAPQOL) in children with cerebral palsy (CP).

Methods

Ninety-seven children with CP (60 males, 37 females; aged 1–6 years) and their caregivers were recruited from the rehabilitation programs of Chang Gung Memorial Hospital in Taiwan for this 6-month longitudinal follow-up study. The Functional Independence Measure for Children (WeeFIM) and TAPQOL outcomes were measured at baseline and at a 6-month follow-up. Responsiveness was examined using the standardized response mean (SRM). The distribution-based and anchor-based MCID were determined. The TAPQOL outcomes include physical functioning (PF), social functioning (SF), cognitive functioning (CF), and emotional functioning (EF) domains.

Results

The responsiveness of the TAPQOL for all of TAPQOL domains was marked (SRM = 1.12–1.54). The anchor-based MCIDs of TAPQOL for PF, SF, CF, EF, and total domains were 1.25, 3.28, 2.93, 2.25, and 1.73, respectively, which were similar to the distribution-based MCID values of TAPQOL, except in the PF domain. The distribution-based MCIDs of TAPQOL in various domains were 2.85–3.73 when effect size (ES) was 0.2, 7.13–9.32 when ES was 0.5, and 11.40–14.91 when ES was 0.8.

Conclusions

TAPQOL is markedly responsive to detect change in children with CP. The caregivers perceived the minimally important change in HRQOL of their children at a relatively low treatment efficacy. Researchers and clinicians can utilize TAPQOL data to determine whether changes in TAPQOL scores indicate clinically meaningful effects post-treatment and at the follow-up.
Literatuur
1.
go back to reference Maenner, M. J., Blumberg, S. J., Kogan, M. D., Christensen, D., Yeargin-Allsopp, M., & Schieve, L. A. (2016). Prevalence of cerebral palsy and intellectual disability among children identified in two US National Surveys, 2011–2013. Annals of Epidemiology,26(3), 222–226.CrossRef Maenner, M. J., Blumberg, S. J., Kogan, M. D., Christensen, D., Yeargin-Allsopp, M., & Schieve, L. A. (2016). Prevalence of cerebral palsy and intellectual disability among children identified in two US National Surveys, 2011–2013. Annals of Epidemiology,26(3), 222–226.CrossRef
2.
go back to reference Wichers, M. J., van der Schouw, Y. T., Moons, K. G., Stam, H. J., & van Nieuwenhuizen, O. (2001). Prevalence of cerebral palsy in The Netherlands (1977–1988). European Journal of Epidemiology,17(6), 527–532.CrossRef Wichers, M. J., van der Schouw, Y. T., Moons, K. G., Stam, H. J., & van Nieuwenhuizen, O. (2001). Prevalence of cerebral palsy in The Netherlands (1977–1988). European Journal of Epidemiology,17(6), 527–532.CrossRef
3.
go back to reference Suzuki, J., & Ito, M. (2002). Incidence patterns of cerebral palsy in Shiga Prefecture, Japan, 1977–1991. Brain and Development,24(1), 39–48.CrossRef Suzuki, J., & Ito, M. (2002). Incidence patterns of cerebral palsy in Shiga Prefecture, Japan, 1977–1991. Brain and Development,24(1), 39–48.CrossRef
4.
go back to reference Takeshita, K., Ando, Y., Ohtani, K., & Takashima, S. (1989). Cerebral palsy in Tottori, Japan. Benefits and risks of progress in perinatal medicine. Neuroepidemiology,8(4), 184–192.CrossRef Takeshita, K., Ando, Y., Ohtani, K., & Takashima, S. (1989). Cerebral palsy in Tottori, Japan. Benefits and risks of progress in perinatal medicine. Neuroepidemiology,8(4), 184–192.CrossRef
12.
go back to reference Varni, J. W., Burwinkle, T. M., Sherman, S. A., Hanna, K., Berrin, S. J., Malcarne, V. L., et al. (2005). Health-related quality of life of children and adolescents with cerebral palsy: Hearing the voices of the children. Developmental Medicine and Child Neurology,47(9), 592–597.CrossRef Varni, J. W., Burwinkle, T. M., Sherman, S. A., Hanna, K., Berrin, S. J., Malcarne, V. L., et al. (2005). Health-related quality of life of children and adolescents with cerebral palsy: Hearing the voices of the children. Developmental Medicine and Child Neurology,47(9), 592–597.CrossRef
15.
go back to reference Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology,56(5), 395–407.CrossRef Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology,56(5), 395–407.CrossRef
18.
go back to reference Coon, C. D., & Cappelleri, J. C. (2016). Interpreting change in scores on patient-reported outcome instruments. Therapeutic Innovation & Regulatory Science,50(1), 22–29.CrossRef Coon, C. D., & Cappelleri, J. C. (2016). Interpreting change in scores on patient-reported outcome instruments. Therapeutic Innovation & Regulatory Science,50(1), 22–29.CrossRef
19.
go back to reference McGlothlin, A. E., & Lewis, R. J. (2014). Minimal clinically important difference: Defining what really matters to patients. The Journal of the American Medical Association,312(13), 1342–1343.CrossRef McGlothlin, A. E., & Lewis, R. J. (2014). Minimal clinically important difference: Defining what really matters to patients. The Journal of the American Medical Association,312(13), 1342–1343.CrossRef
20.
go back to reference Fekkes, M., Theunissen, N. C., Brugman, E., Veen, S., Verrips, E. G., Koopman, H. M., et al. (2000). Development and psychometric evaluation of the TAPQOL: A health-related quality of life instrument for 1-5-year-old children. Quality of Life Research,9(8), 961–972.CrossRef Fekkes, M., Theunissen, N. C., Brugman, E., Veen, S., Verrips, E. G., Koopman, H. M., et al. (2000). Development and psychometric evaluation of the TAPQOL: A health-related quality of life instrument for 1-5-year-old children. Quality of Life Research,9(8), 961–972.CrossRef
24.
go back to reference Palisano, R., Rosenbaum, P., Walter, S., Russell, D., Wood, E., & Galuppi, B. (1997). Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental Medicine and Child Neurology,39(4), 214–223.CrossRef Palisano, R., Rosenbaum, P., Walter, S., Russell, D., Wood, E., & Galuppi, B. (1997). Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental Medicine and Child Neurology,39(4), 214–223.CrossRef
26.
go back to reference Sperle, P. A., Ottenbacher, K. J., Braun, S. L., Lane, S. J., & Nochajski, S. (1997). Equivalence reliability of the functional independence measure for children (WeeFIM) administration methods. American Journal of Occupational Therapy,51(1), 35–41.CrossRef Sperle, P. A., Ottenbacher, K. J., Braun, S. L., Lane, S. J., & Nochajski, S. (1997). Equivalence reliability of the functional independence measure for children (WeeFIM) administration methods. American Journal of Occupational Therapy,51(1), 35–41.CrossRef
27.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: Lawrence Erlbaum Associates. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: Lawrence Erlbaum Associates.
28.
30.
go back to reference Samsa, G., Edelman, D., Rothman, M. L., Williams, G. R., Lipscomb, J., & Matchar, D. (1999). Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics,15(2), 141–155.CrossRef Samsa, G., Edelman, D., Rothman, M. L., Williams, G. R., Lipscomb, J., & Matchar, D. (1999). Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics,15(2), 141–155.CrossRef
34.
go back to reference Newton, A. S., & Wild, C. T. (2016). Is it time to define minimally clinically important differences for patient-reported outcome measures used in alcohol brief intervention studies? Addiction,111(9), 1528–1529.CrossRef Newton, A. S., & Wild, C. T. (2016). Is it time to define minimally clinically important differences for patient-reported outcome measures used in alcohol brief intervention studies? Addiction,111(9), 1528–1529.CrossRef
35.
go back to reference Samsa, G., Edelman, D., Rothman, M. L., Williams, G. R., Lipscomb, J., & Matchar, D. (1999). Determining clinically important differences in health status measures. Pharmacoeconomics,15(2), 141–155.CrossRef Samsa, G., Edelman, D., Rothman, M. L., Williams, G. R., Lipscomb, J., & Matchar, D. (1999). Determining clinically important differences in health status measures. Pharmacoeconomics,15(2), 141–155.CrossRef
36.
go back to reference Anttila, H., Autti-Rämö, I., Suoranta, J., Mäkelä, M., & Malmivaara, A. (2008). Effectiveness of physical therapy interventions for children with cerebral palsy: A systematic review. BMC Pediatrics,8(1), 14.CrossRef Anttila, H., Autti-Rämö, I., Suoranta, J., Mäkelä, M., & Malmivaara, A. (2008). Effectiveness of physical therapy interventions for children with cerebral palsy: A systematic review. BMC Pediatrics,8(1), 14.CrossRef
Metagegevens
Titel
Responsiveness and minimal clinically important difference of TNO-AZL Preschool Children Quality of Life in children with cerebral palsy
Auteurs
Chia-ling Chen
I-hsuan Shen
Hsiang-Han Huang
Chung-yao Chen
Yi-ting Hsiao
Ching-yi Wu
Hsieh-Ching Chen
Publicatiedatum
28-11-2019
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 3/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-019-02370-y

Andere artikelen Uitgave 3/2020

Quality of Life Research 3/2020 Naar de uitgave